Trial Profile
Phase I Trial of Cisplatin and Pemetrexed in Combination With Panobinostat in Advanced Solid Tumors, With Emphasis on Non-Small Cell Lung Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Panobinostat (Primary) ; Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer; Solid tumours
- Focus Adverse reactions
- 02 Jun 2017 Status changed from active, no longer recruiting to completed.
- 19 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 19 Jan 2017 Planned primary completion date changed from 1 Dec 2014 to 1 Jun 2017.